Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated hepatic lipase gene expression

被引:19
作者
Botma, GJ
van Deursen, D
Vieira, D
van Hoek, M
Jansen, H
Verhoeven, AJM
机构
[1] Erasmus MC, COEUR Cardiovasc Res Sch, Dept Biochem, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus MC, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands
[3] Erasmus MC, Dept Clin Chem, NL-3000 DR Rotterdam, Netherlands
关键词
hepatic lipase; SREBP; USF; unsaturated fatty acids; statin; lipid homeostasis;
D O I
10.1016/j.atherosclerosis.2004.10.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatic lipase (HL) not only plays an important role in plasma lipoprotein transport, but may also affect intracellular lipid metabolism. We hypothesize that HL expression is regulated as an integral part of intracellular lipid homeostasis. Addition of oleate (1 mM) to HepG2 cells increased HL secretion to 134 +/- 14% of control (p < 0.02), and increased the transcriptional activity of a 698-bp HL promoter-reporter construct two-fold. Atorvastatin (10 mu M) abolished the oleate stimulation. The transcriptional activity of a sterol-regulatory-element binding protein (SREBP)-sensitive HMG-CoA synthase promoter construct was reduced 50% by oleate, and increased 2-3-fold by atorvastatin. Co-transfection with an SREBP-2 expression vector reduced HL promoter activity and increased HMG-CoA synthase promoter activity. Upstream stimulatory factors (USF) are also implicated in maintenance of lipid homeostasis. Co-transfection with a USF-1 expression vector stimulated HL promoter activity 4-6-fold. The USF-stimulated HL promoter activity was not further enhanced by oleate, but almost completely prevented by atorvastatin or co-transfection with the SREBP-2 vector. Opposite regulation by VSF-1 and SREBP-2 was also observed with a 318-bp HL promoter construct that lacks potential SRE-like and E-box binding motifs. We conclude that the opposite regulation of HL expression by fatty acids and statins is mediated via SREBP, possibly through interaction with USE (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:61 / 67
页数:7
相关论文
共 25 条
  • [1] AMEIS D, 1990, J BIOL CHEM, V265, P6552
  • [2] Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes -: Effect of sex and the LIPC promoter variant
    Berk-Planken, IIL
    Hoogerbrugge, N
    Stolk, RP
    Bootsma, AH
    Jansen, H
    [J]. DIABETES CARE, 2003, 26 (02) : 427 - 432
  • [3] Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor
    Botma, GJ
    Verhoeven, AJM
    Jansen, H
    [J]. ATHEROSCLEROSIS, 2001, 154 (03) : 625 - 632
  • [4] The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity
    Carr, MC
    Hokanson, JE
    Zambon, A
    Deeb, SS
    Barrett, PHR
    Purnell, JQ
    Brunzell, JD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (06) : 2831 - 2837
  • [5] Hepatic lipase: new insights from genetic and metabolic studies
    Cohen, JC
    Vega, GL
    Grundy, SM
    [J]. CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (03) : 259 - 267
  • [6] Deeb SS, 2000, J LIPID RES, V41, P155
  • [7] HUMAN TRANSCRIPTION FACTOR USF STIMULATES TRANSCRIPTION THROUGH THE INITIATOR ELEMENTS OF THE HIV-1 AND THE AD-ML PROMOTERS
    DU, H
    ROY, AL
    ROEDER, RG
    [J]. EMBO JOURNAL, 1993, 12 (02) : 501 - 511
  • [8] Low hepatic lipase activity is a novel risk factor for coronary artery disease
    Dugi, KA
    Brandauer, K
    Schmidt, N
    Nau, B
    Schneider, JG
    Mentz, S
    Keiper, T
    Schaefer, JR
    Meissner, C
    Kather, H
    Bahner, ML
    Fiehn, W
    Kreuzer, J
    [J]. CIRCULATION, 2001, 104 (25) : 3057 - 3062
  • [9] Regulation of gene expression by SREBP and SCAP
    Edwards, PA
    Tabor, D
    Kast, HR
    Venkateswaran, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1529 (1-3): : 103 - 113
  • [10] Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia
    Hoogerbrugge, N
    Jansen, H
    [J]. ATHEROSCLEROSIS, 1999, 146 (01) : 167 - 174